Detail of the clinical trial

Title of the trial A randomised, phase 3 study in previously untreated patients with biological high-risk CLL: fludarabin + cyclophosphamide (FC) versus FC + low-dose alemtuzumab
EudraCT number 2005-000309-75
Protocol number HOVON68
Sponsor HOVON CLL Group, Rotterdam, Netherlands
Indications Hemato-oncology
Diagnosis chronic lymphocytic leukemia
Population in clinical trial Adults (18-65 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2006
Date of approval by Institute (SÚKL) 31.05.2007
Date of approval by EC 13.02.2008
Date of initiation CT in ČR
Date of ending CT in ČR
Notice
Sites Hematologická klinika, Fakultní nemocnice Královské Vinohrady, Šrobárova 50, 100 34 PRAHA 10

‹‹ Back to list